These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1071 related items for PubMed ID: 25560712

  • 41. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
    Bjøri E, Johnsen HS, Hansen JB, Braekkan SK.
    J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
    [Abstract] [Full Text] [Related]

  • 42. Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study.
    Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A, Testa S, Prisco D, Poli D, Tripodi A, Marongiu F, Palareti G, PROLONG Investigators (on behalf of Italian Federation of Anticoagulation Clinics).
    Blood; 2010 Jan 21; 115(3):481-8. PubMed ID: 19965693
    [Abstract] [Full Text] [Related]

  • 43. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.
    van Belle A, Büller HR, Huisman MV, Huisman PM, Kaasjager K, Kamphuisen PW, Kramer MH, Kruip MJ, Kwakkel-van Erp JM, Leebeek FW, Nijkeuter M, Prins MH, Sohne M, Tick LW, Christopher Study Investigators.
    JAMA; 2006 Jan 11; 295(2):172-9. PubMed ID: 16403929
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.
    Rodger MA, Le Gal G, Anderson DR, Schmidt J, Pernod G, Kahn SR, Righini M, Mismetti P, Kearon C, Meyer G, Elias A, Ramsay T, Ortel TL, Huisman MV, Kovacs MJ, REVERSE II Study Investigators.
    BMJ; 2017 Mar 17; 356():j1065. PubMed ID: 28314711
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G, Kovacs MJ, Carrier M, Do K, Kahn SR, Wells PS, Anderson DA, Chagnon I, Solymoss S, Crowther M, Righini M, Lacut K, White RH, Vickars L, Rodger M.
    Thromb Haemost; 2010 Sep 17; 104(3):498-503. PubMed ID: 20539910
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The benefit of D-Dimer testing to decide on stopping anticoagulation after a first unprovoked VTE: a matter of sex or of test sensitivity?
    Czihal M, Reinecke H.
    Vasa; 2015 Sep 17; 44(5):399. PubMed ID: 26317262
    [No Abstract] [Full Text] [Related]

  • 52. Rapid quantitative D-dimer to exclude pulmonary embolism: a prospective cohort management study.
    Bates SM, Takach Lapner S, Douketis JD, Kearon C, Julian J, Parpia S, Schulman S, Weitz JI, Linkins LA, Crowther M, Lim W, Spencer FA, Lee AY, Gross PL, Ginsberg J.
    J Thromb Haemost; 2016 Mar 17; 14(3):504-9. PubMed ID: 26707364
    [Abstract] [Full Text] [Related]

  • 53. D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry.
    Grau E, Tenías JM, Soto MJ, Gutierrez MR, Lecumberri R, Pérez JL, Tiberio G, RIETE Investigators.
    Crit Care Med; 2007 Aug 17; 35(8):1937-41. PubMed ID: 17581488
    [Abstract] [Full Text] [Related]

  • 54. Should D-dimer testing be used to predict the risk of recurrence after discontinuation of anticoagulant therapy for a first unprovoked episode of venous thromboembolism?
    Wu C, Bates SM.
    Pol Arch Med Wewn; 2009 Apr 17; 119(4):225-30. PubMed ID: 19413181
    [Abstract] [Full Text] [Related]

  • 55. Aspirin for preventing the recurrence of venous thromboembolism.
    Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P, WARFASA Investigators.
    N Engl J Med; 2012 May 24; 366(21):1959-67. PubMed ID: 22621626
    [Abstract] [Full Text] [Related]

  • 56. Duration of anticoagulation therapy for venous thromboembolism.
    Bounameaux H, Perrier A.
    Hematology Am Soc Hematol Educ Program; 2008 May 24; ():252-8. PubMed ID: 19074092
    [Abstract] [Full Text] [Related]

  • 57. "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?
    Rodger MA, Le Gal G, Langlois NJ, Gin B, Mallick R, Giulivi A, Freedman M, Kovacs MJ, REVERSE II investigatorsThe Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada..
    Thromb Res; 2018 Sep 24; 169():82-86. PubMed ID: 30031290
    [Abstract] [Full Text] [Related]

  • 58. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).
    Franco Moreno AI, García Navarro MJ, Ortiz Sánchez J, Martín Díaz RM, Madroñal Cerezo E, de Ancos Aracil CL, Cabello Clotet N, Perales Fraile I, Gimeno García S, Montero Hernández C, Zapatero Gaviria A, Ruiz Giardín JM.
    Eur J Intern Med; 2016 Apr 24; 29():59-64. PubMed ID: 26775136
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.